Orphan drug status granted in the United States for a drug that could treat psc

IDN-7314 Granted orphan drug status in the United States.

Conatus’s PSC Candidate Gets Orphan Designation in the US

Zacks.com - 1d ago

Conatus Pharmaceuticals Inc.'s (CNAT - Free Report) shares increased almost 10% after the biotech company announced FDA’s grant of Orphan Drug Designation (ODD) to its pipeline candidate IDN-7314 for treatment of primary sclerosing cholangitis (PSC) …

1 Like

Only 10% and also too early to have any thoughts.